Pharmacotherapy of atrial fibrilation
Pharmacotherapy of atrial fibrilation
Dátum
Szerzők
Khatib, Abd El Rahman
Folyóirat címe
Folyóirat ISSN
Kötet címe (évfolyam száma)
Kiadó
Absztrakt
AF (atrial fibrillation) is one of the most common cardiac diseases seen in the hospital. It is
considered a high risk factor for stroke and can leads to life threatening arrhythmias. It is an
obligation upon each and every physician to be familiar with this cardiac arrhythmia in order to
decrease morbidity and mortality. Pharmacotherapy is used as an essential therapy for cessation of
AF and to prevent the thromboembolic complications.
This thesis attempts to shed light on the different pharmacotherapy available for this particular
disease namely rate control drugs: BB (beta blocker), CCB (calcium channel blocker) and digoxin,
rhythm control drugs: class I c, class III and multichannel blocker and anticoagulation drugs:
NOAC (New oral Anticoagulation drugs) and VKA (vitamin K antagonists)
Leírás
Kulcsszavak
pharmacology